Research Article
MCP-4 and Eotaxin-3 Are Novel Biomarkers for Chronic Obstructive Pulmonary Disease
Figure 4
Protein levels of MCP-4 and eotaxin-3 were upregulated in HBEs stimulated with LPS. (a, b) Expression of MCP-4 and eotaxin-3 in culture medium of HBEs was increased after the treatment with LPS (0.01–1 µg/mL) in a dose-dependent manner. (c, d) LPS-stimulated upregulation of MCP-4 and eotaxin-3 in HBEs exhibited a time-dependent manner. ∗. MCP-4, monocyte chemoattractant protein.
(a) |
(b) |
(c) |
(d) |